In NAFLD, key molecules in the non-canonical NF-κB signaling pathway such as BAFF, CD40L, TRAF2, TRAF3, NIK, and p52 are abnormally elevated [1,2,15,18,20]. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.